Citation 81865

SHIN,JG: SEO,YW: CHO,KW: RHO,JR: PAUL,VJ:. (1998). OSIRISYNES A-F, HIGHLY OXYGENATED POLYACETYLENES FROM THE SPONGE HALICLONA AOSIRIS.. 54(30)

Citation Details

Title	OSIRISYNES A-F, HIGHLY OXYGENATED POLYACETYLENES FROM THE SPONGE HALICLONA AOSIRIS.
Authors	SHIN,JG: SEO,YW: CHO,KW: RHO,JR: PAUL,VJ:
Year	1998
Volume	54
Issue	30

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Haliclona osiris (HALICLONIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OSIRISYNE A	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OSIRISYNE A	WEAK ACTIVITY
3	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OSIRISYNE B	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OSIRISYNE B	WEAK ACTIVITY
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OSIRISYNE C	None
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OSIRISYNE C	WEAK ACTIVITY
7	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSIRISYNE C	ACTIVE
8	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSIRISYNE C	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OSIRISYNE D	None
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OSIRISYNE D	WEAK ACTIVITY
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OSIRISYNE E	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OSIRISYNE E	WEAK ACTIVITY
13	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSIRISYNE E	ACTIVE
14	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSIRISYNE E	ACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OSIRISYNE F	None
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OSIRISYNE F	WEAK ACTIVITY
17	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSIRISYNE F	ACTIVE
18	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSIRISYNE F	ACTIVE

Show SPARQL Queries (1)